Bej Erjola, Cesare Patrizia, Volpe Anna Rita, d'Angelo Michele, Castelli Vanessa
Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.
Neurol Int. 2024 Apr 29;16(3):502-517. doi: 10.3390/neurolint16030037.
Parkinson's disease (PD) is a progressive neurodegenerative condition marked by the gradual deterioration of dopaminergic neurons in the . Oxidative stress has been identified as a key player in the development of PD in recent studies. In the first part, we discuss the sources of oxidative stress in PD, including mitochondrial dysfunction, dopamine metabolism, and neuroinflammation. This paper delves into the possibility of mitigating oxidative stress as a potential treatment approach for PD. In addition, we examine the hurdles and potential of antioxidant therapy, including the challenge of delivering antioxidants to the brain and the requirement for biomarkers to track oxidative stress in PD patients. However, even if antioxidant therapy holds promise, further investigation is needed to determine its efficacy and safety in PD treatment.
帕金森病(PD)是一种进行性神经退行性疾病,其特征是[此处原文缺失部位]中多巴胺能神经元逐渐退化。氧化应激在最近的研究中已被确定为帕金森病发展的关键因素。在第一部分,我们讨论帕金森病中氧化应激的来源,包括线粒体功能障碍、多巴胺代谢和神经炎症。本文深入探讨了减轻氧化应激作为帕金森病潜在治疗方法的可能性。此外,我们研究了抗氧化治疗的障碍和潜力,包括将抗氧化剂输送到大脑的挑战以及追踪帕金森病患者氧化应激的生物标志物的需求。然而,即使抗氧化治疗有前景,仍需要进一步研究以确定其在帕金森病治疗中的疗效和安全性。